{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T19:31:40Z","timestamp":1781897500545,"version":"3.54.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CURR MED SCI"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s11596-021-2379-1","type":"journal-article","created":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T01:02:54Z","timestamp":1624582974000},"page":"548-554","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Ligustrazine Attenuates Hyperhomocysteinemia-induced Alzheimer-like Pathologies in Rats"],"prefix":"10.1007","volume":"41","author":[{"given":"Qing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-jie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-xiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-hu","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,25]]},"reference":[{"issue":"3","key":"2379_CR1","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jalz.2007.04.381","volume":"3","author":"R Brookmeyer","year":"2007","unstructured":"Brookmeyer R, Johnson E, Ziegler-Graham K, et al. Forecasting the global burden of Alzheimer\u2019s disease. Alzheimers Dement, 2007,3(3):186\u2013191","journal-title":"Alzheimers Dement"},{"issue":"1","key":"2379_CR2","first-page":"1","volume":"44","author":"RA Armstrong","year":"2006","unstructured":"Armstrong RA. Plaques and tangles and the pathogenesis of Alzheimer\u2019s disease. Folia Neuropathol, 2006,44(1): 1\u201311","journal-title":"Folia Neuropathol"},{"issue":"3","key":"2379_CR3","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.neulet.2006.09.044","volume":"409","author":"E Portelius","year":"2006","unstructured":"Portelius E, Zetterberg H, Andreasson U, et al. An Alzheimer\u2019s disease-specific \u03b2-amyloid fragment signature in cerebrospinal fluid. Neurosci Lett, 2006,409(3):215\u2013219","journal-title":"Neurosci Lett"},{"key":"2379_CR4","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jnutbio.2018.02.001","volume":"55","author":"D Mendes","year":"2018","unstructured":"Mendes D, Oliveira MM, Moreira PI, et al. Beneficial effects of white wine polyphenols-enriched diet on Alzheimer\u2019s disease-like pathology. J Nutr Biochem, 2018,55:165\u2013177","journal-title":"J Nutr Biochem"},{"issue":"2 Suppl","key":"2379_CR5","doi-asserted-by":"publisher","first-page":"S143","DOI":"10.1177\/15648265080292S119","volume":"29","author":"AD Smith","year":"2008","unstructured":"Smith AD. The worldwide challenge of the dementias: a role for B vitamins and homocysteine? Food Nutr Bull, 2008,29(2 Suppl):S143\u2013S172","journal-title":"Food Nutr Bull"},{"issue":"1","key":"2379_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1373\/clinchem.2003.021634","volume":"50","author":"H Refsum","year":"2004","unstructured":"Refsum H, Smith AD, Ueland PM, et al. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin Chem, 2004,50(1):3\u201332","journal-title":"Clin Chem"},{"issue":"7","key":"2379_CR7","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1056\/NEJMoa011613","volume":"346","author":"S Seshadri","year":"2002","unstructured":"Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer\u2019s disease. N Engl J Med, 2002,346(7):476\u2013483","journal-title":"N Engl J Med"},{"issue":"11","key":"2379_CR8","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1001\/archneur.55.11.1449","volume":"55","author":"R Clarke","year":"1998","unstructured":"Clarke R, Smith AD, Jobst KA, et al. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol, 1998,55(11):1449\u20131455","journal-title":"Arch Neurol"},{"issue":"16","key":"2379_CR9","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1212\/WNL.0b013e3181f88162","volume":"75","author":"B Hooshmand","year":"2010","unstructured":"Hooshmand B, Solomon A, Kareholt I, et al. Homocysteine and holotranscobalamin and the risk of Alzheimer disease: a longitudinal study. Neurology, 2010,75(16): 1408\u20131414","journal-title":"Neurology"},{"issue":"3","key":"2379_CR10","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1093\/ajcn\/82.3.636","volume":"82","author":"G Ravaglia","year":"2005","unstructured":"Ravaglia G, Forti P, Maioli F, et al. Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am J Clin Nutr, 2005,82(3):636\u2013643","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"2379_CR11","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s12264-018-0249-z","volume":"34","author":"BL Sun","year":"2018","unstructured":"Sun BL, Li WW, Zhu C, et al. Clinical research on Alzheimer\u2019s disease: progress and perspectives. Neurosci Bull, 2018,34(6):1111\u20131118","journal-title":"Neurosci Bull"},{"key":"2379_CR12","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1007\/s11164-013-1281-2","volume":"41","author":"K Xu","year":"2015","unstructured":"Xu K, Wang PL, Xu X, et al. An overview on structural modifications of ligustrazine and iological evaluation of its synthetic derivatives. Res Chem Intermediat, 2015,41:1385\u20131411","journal-title":"Res Chem Intermediat"},{"issue":"3","key":"2379_CR13","first-page":"180","volume":"19","author":"C Zhang","year":"2004","unstructured":"Zhang C, Wang SZ, Zuo PP, et al. Protective effect of tetramethylpyrazine on learning and memory function in D-galactose-lesioned mice, Chin Med Sci J, 2004,19(3):180\u2013184","journal-title":"Chin Med Sci J"},{"issue":"11","key":"2379_CR14","doi-asserted-by":"publisher","first-page":"5609","DOI":"10.1016\/j.ejmech.2011.09.030","volume":"46","author":"HF Chen","year":"2012","unstructured":"Chen HF, Li GN, Zhan P, et al. Ligustrazine derivatives. Part 5: design, synthesis and biological evaluation of novel ligustrazinyloxy-cinnamic acid derivatives as potent cardiovascular agents. Eur J Med Chem, 2012,46(11): 5609\u20135615","journal-title":"Eur J Med Chem"},{"key":"2379_CR15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.neuropharm.2017.03.022","volume":"118","author":"T Zhang","year":"2017","unstructured":"Zhang T, Gu JB, Wu LM, et al. Neuroprotective and axonal outgrowth-promoting effects of tetramethylpyrazine nitrone in chronic cerebral hypoperfusion rats and primary hippocampal neurons exposed to hypoxia. Neuropharmacology, 2017,118:137\u2013147","journal-title":"Neuropharmacology"},{"issue":"4","key":"2379_CR16","doi-asserted-by":"publisher","first-page":"350","DOI":"10.7150\/ijbs.8366","volume":"10","author":"C Lu","year":"2014","unstructured":"Lu C, Zhang J, Shi XP, et al. Neuroprotective effects of tetramethylpyrazine against dopaminergic neuron injury in a rat model of Parkinson\u2019s disease induced by MPTP. Int J Biol Sci, 2014,10(4):350\u2013357","journal-title":"Int J Biol Sci"},{"issue":"5","key":"2379_CR17","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/BF02256534","volume":"9","author":"EC So","year":"2002","unstructured":"So EC, Wong KL, Huang TC, et al. Tetramethylpyrazine protects mice against thioacetamide-induced acute hepatotoxicity. J Biomed Sci, 2002,9(5):410\u2013414","journal-title":"J Biomed Sci"},{"issue":"1","key":"2379_CR18","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.neulet.2008.09.007","volume":"449","author":"XL Zhu","year":"2009","unstructured":"Zhu XL, Xiong LZ, Wang Q, et al. Therapeutic time window and mechanism of tetramethylpyrazine on transient focal cerebral ischemia\/reperfusion injury in rats. Neurosci Lett, 2009,449(1):24\u201327","journal-title":"Neurosci Lett"},{"key":"2379_CR19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/1471-2202-7-48","volume":"7","author":"LH Fan","year":"2006","unstructured":"Fan LH, Wang KZ, Cheng B, et al. Anti-apoptotic and neuroprotective effects of tetramethylpyrazine following spinal cord ischemia in rabbits. BMC Neurosci, 2006,7:48","journal-title":"BMC Neurosci"},{"issue":"5","key":"2379_CR20","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.cellbi.2006.10.001","volume":"31","author":"XR Cheng","year":"2007","unstructured":"Cheng XR, Zhang L, Hu JJ, et al. Neuroprotective effects of tetramethylpyrazine on hydrogen peroxide-induced apoptosis in PC12 cells. Cell Biol Int, 2007,31(5):438\u2013443","journal-title":"Cell Biol Int"},{"issue":"1","key":"2379_CR21","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/iub.1704","volume":"70","author":"TF Zhao","year":"2018","unstructured":"Zhao TF, Fu YX, Sun H, et al. Ligustrazine suppresses neuron apoptosis via the Bax\/Bcl-2 and caspase-3 pathway in PC12 cells and in rats with vascular dementia. IUBMB Life, 2018,70(1): 60\u201370","journal-title":"IUBMB Life"},{"issue":"8","key":"2379_CR22","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/j.neurobiolaging.2011.06.008","volume":"33","author":"C Singh","year":"2012","unstructured":"Singh C, Liu LF, Wang JM, et al. Allopregnanolone restores hippocampal-dependent learning and memory and neural progenitor survival in aging 3xTg AD and nonTg mice. Neurobiol Aging, 2012,33(8):1493\u20131506","journal-title":"Neurobiol Aging"},{"issue":"1","key":"2379_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1006\/neur.1995.0002","volume":"4","author":"JP Brion","year":"1995","unstructured":"Brion JP, Couck AM, Conreur JL. Calcineurin (phosphatase 2B) is present in neurons containing neurofibrillary tangles and in a subset of senile plaques in Alzheimer\u2019s disease. Neurodegeneration, 1995,4(1):13\u201321","journal-title":"Neurodegeneration"},{"issue":"1","key":"2379_CR24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0304-3940(97)00230-9","volume":"226","author":"L Minthon","year":"1997","unstructured":"Minthon L, Hesse C, Sjogren M, et al. The apolipoprotein E epsilon4 allele frequency is normal in fronto-temporal dementia, but correlates with age at onset of disease. Neurosci Lett, 1997,226(1):65\u201367","journal-title":"Neurosci Lett"},{"issue":"6","key":"2379_CR25","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s004010051040","volume":"97","author":"M Takahashi","year":"1999","unstructured":"Takahashi M, Tsujioka Y, Yamada T, et al. Glycosylation of microtubule-associated protein tau in Alzheimer\u2019s disease brain. Acta Neuropathol, 1999,97(6):635\u2013641","journal-title":"Acta Neuropathol"},{"issue":"5","key":"2379_CR26","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s11910-001-0105-8","volume":"1","author":"C Janus","year":"2001","unstructured":"Janus C, Phinney AL, Chishti MA, et al. New developments in animal models of Alzheimer\u2019s disease. Curr Neurol Neurosci Rep, 2001,1(5):451\u2013457","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"4","key":"2379_CR27","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1312889","volume":"370","author":"RS Doody","year":"2014","unstructured":"Doody RS, Thomas RG, Farlow M, et al. Phase 3 trials of solanezumab for mild-to-moderate Alzheimer\u2019s disease. N Engl J Med, 2014,370(4):311\u2013321","journal-title":"N Engl J Med"},{"issue":"8","key":"2379_CR28","first-page":"1088","volume":"24","author":"L Zhao","year":"2008","unstructured":"Zhao L, Wei M, He M, et al. The effects of tetramethylpyrazine on learning and memory abilities of mice with Alzheimer disease and its possible mechanism. Chin Pharmacol Bull, 2008,24(8):1088\u20131092","journal-title":"Chin Pharmacol Bull"},{"issue":"2","key":"2379_CR29","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1208\/s12249-012-9767-6","volume":"13","author":"J Shi","year":"2012","unstructured":"Shi J, Wang YM, Luo GA. Ligustrazine phosphate ethosomes for treatment of Alzheimer\u2019s Disease, in vitro and in animal model studies. AAPS PharmSciTech, 2012,13(2):485\u2013492","journal-title":"AAPS PharmSciTech"},{"issue":"5","key":"2379_CR30","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.3892\/etm.2015.2365","volume":"9","author":"F Tan","year":"2015","unstructured":"Tan F, Fu WJ, Cheng NF, et al. Ligustrazine reduces blood-brain barrier permeability in a rat model of focal cerebral ischemia and reperfusion. Exp Ther Med, 2015,9(5):1757\u20131762","journal-title":"Exp Ther Med"},{"issue":"6","key":"2379_CR31","first-page":"771","volume":"27","author":"CF Qi","year":"2007","unstructured":"Qi CF, Liu Y, Zhang JS, et al. Effect of ligustrazine on nNOS expression and neuranagenesis in adult rats after cerebral ischemia-reperfusion injury. Nan Fang Yi Ke Da Xue Xue Bao (Chinese), 2007,27(6):771\u2013774","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao (Chinese)"},{"issue":"13","key":"2379_CR32","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1016\/j.febslet.2006.04.088","volume":"580","author":"R Obeid","year":"2006","unstructured":"Obeid R, Herrmann W. Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett, 2006,580(13):2994\u20133005","journal-title":"FEBS Lett"}],"container-title":["Current Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-021-2379-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11596-021-2379-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-021-2379-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,11]],"date-time":"2021-07-11T17:16:50Z","timestamp":1626023810000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11596-021-2379-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["2379"],"URL":"https:\/\/doi.org\/10.1007\/s11596-021-2379-1","relation":{},"ISSN":["2096-5230","2523-899X"],"issn-type":[{"value":"2096-5230","type":"print"},{"value":"2523-899X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"31 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest Statement"}}]}}